Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05104515
Title First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oxford Vacmedix UK Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR


No variant requirements are available.